v3.26.3
Condensed Statements of Operations - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]            
Revenue
Operating expenses:            
Research and development 503,020 146,901 685,167 316,605 1,255,266 2,103,366
General and administrative 3,285,481 489,325 3,988,926 861,071 2,512,470 1,917,154
Depreciation 1,159 1,158 2,317 2,317 4,634 6,300
Total operating expenses 3,789,660 637,384 4,676,410 1,179,993 3,772,370 4,026,820
Loss from operations (3,789,660) (637,384) (4,676,410) (1,179,993) (3,772,370) (4,026,820)
Other income (expense):            
Interest income 28,285 5,390 29,363 9,697 25,614 142,596
Interest expense (10,633) (23,949) (48,852) (25,264) (100,881) (5,000)
Loss on fraud incident         (1,042,459)
Realized loss on investment         (722)
Other income 600 77,000
Total other income (expense), net 17,652 (18,559) (18,889) (15,567) (75,267) (828,585)
Net loss $ (3,772,008) $ (655,943) $ (4,695,299) $ (1,195,560) $ (3,847,637) $ (4,855,405)
Basic net loss per common share (in Dollars per share) $ (2.75) $ (1.66) $ (5.01) $ (3.15) $ (8.4) $ (9.92)
Diluted net loss per common share (in Dollars per share) $ (2.75) $ (1.66) $ (5.01) $ (3.15) $ (8.4) $ (9.92)
Weighted average number of common shares outstanding, basic (in Shares) 1,419,767 694,450 1,061,697 694,450 696,373 691,006
Weighted average number of common shares outstanding, diluted (in Shares) 1,419,767 694,450 1,061,697 694,450 696,373 691,006